查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2099352

血壓監測設備：市場洞察、競爭格局及市場預測 - 2034 年

Blood Pressure Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

血壓監測設備市場概述

概述：

  • 預計到 2025 年，血壓監測設備市場規模將達到 42 億美元，到 2034 年將達到 96 億美元。這一成長是由全球高血壓和心血管疾病負擔日益加重、家用和自我監測設備普及率加快以及數位化、互聯互通和人工智慧驅動的醫療保健技術日益融合所推動的。
  • 全球血壓監測設備市場預計在 2026 年至 2034 年的預測期內將以 9.6% 的複合年成長率成長。
  • 按產品類別分類，預計到 2025 年，數位/自動血壓監測儀細分市場將佔 64% 的市場佔有率，從而推動血壓監測設備市場的發展。
  • 就最終用戶而言，「居家照護」領域預計到 2025 年將佔 58% 的市場佔有率，從而推動血壓監測設備市場的發展。
  • 預計到 2025 年，北美將佔 39% 的市場佔有率，在全球血壓監測設備銷售中佔主導地位，並在全球範圍內取得最高的市場佔有率。

血壓監測設備是一種診斷儀器，用於在臨床、門診和居家照護環境中測量收縮壓和舒張壓，以篩檢、診斷和管理高血壓和心血管疾病。該市場包括採用示波法和日益普及的無袖帶感測技術的數位/自動血壓監測儀，例如穿戴式式、上臂式、腕式和指尖式血壓監測儀；以及手動血壓監測儀，例如水銀血壓計和表式血壓計，由於其成本低廉且透過聽診法測量精度高，因此仍然被廣泛使用。這些設備正在醫院、門診手術中心、居家照護機構和其他醫療保健環境中部署，並且隨著具備藍牙和Wi-Fi連接功能的智慧血壓監測儀與行動醫療應用程式、電子健康記錄和遠端患者監護平台整合，其普及速度正在加快。受全球高血壓盛行率上升、人口老化、消費者健康意識增強以及無袖帶、人工智慧驅動和心房顫動檢測技術的不斷創新推動，血壓監測設備已成為支持臨床心血管護理以及不斷擴展的居家醫療和數位健康生態系統的重要工具。

血壓監測設備市場的主要市場促進因素

  • 全球高血壓負擔日益加重是推動相關設備需求的根本原因。公共衛生數據顯示，全球超過11.3億成年人患有高血壓，每年有超過760萬人死於該疾病。這持續推高了對篩檢和監測設備的結構性需求。
  • 消費者越來越偏好在家中進行血壓自我監測，這推動了對數位上臂血壓計、腕式血壓計和穿戴式血壓計的需求成長。這是因為患者希望能夠在診所外輕鬆追蹤自身的血壓狀況，並遠端與醫生共用測量數據。
  • 包括藍牙和 Wi-Fi 連接、無袖帶和光學感測以及人工智慧驅動的心房顫動檢測在內的快速技術進步，正在擴展連網血壓監測儀的功能和臨床價值。
  • 老年人口不斷增加，加上肥胖、糖尿病和久坐不動的生活方式的盛行，導致心血管疾病的風險上升，需要定期監測血壓的患者人數也在增加。
  • 隨著遠端醫療和遠端患者監護生態系統的擴展，連網血壓監測設備與行動醫療應用程式、電子健康記錄系統和虛擬護理平台的整合正在加強。
  • 嚴格的精度和檢驗標準，包括 ISO 81060-2:2018+A1:2020 以及歐洲高血壓學會和美國心臟協會認證的方案，迫使製造商開發更準確、經過臨床檢驗的設備。
  • 領先的製造商透過策略性投資、新產品發布和併購活動，例如飛利浦於 2025 年 12 月完成對 EarlySense 的收購，以及於 2025 年 9 月與 Masimo 續簽多年病患監測夥伴關係關係，正在加強互聯監護產品系列。
  • 高血壓盛行率上升、居家醫療日益普及以及數位健康技術的融合，這些都是促成市場在 2034 年之前保持穩定、接近兩位數成長的因素。

推動血壓監測設備市場成長的因素

市場促進因素

全球高血壓與心血管疾病負擔日益加重

血壓監測設備市場最大的驅動力是全球高血壓負擔的嚴重程度。公共衛生調查顯示，全球超過11.3億成年人患有高血壓，這種疾病每年導致超過760萬人死亡，是心血管疾病、中風和腎衰竭的主要可控危險因子。儘管高血壓的盛行率如此之高，但在許多地區，人們對高血壓的認知和治療率仍然不足，因此正在進行諸如「五月測量月」之類的公共衛生宣傳活動，以擴大篩檢的覆蓋範圍。隨著人口老化和生活方式相關危險因子導致心血管疾病發生率持續上升，醫院、診所和家庭對準確易用的血壓監測設備的需求不斷成長，這為2034年之前的市場成長奠定了基礎。

人們越來越傾向於在家中進行自我測量。

居家血壓管理模式的轉變是推動市場成長的主要動力。患者和醫生越來越傾向於自我監測，因為這有助於降低醫療成本，提供比零星門診就診更具代表性的血壓讀數，並有助於發現白大衣高血壓和隱性高血壓。這種轉變帶動了對小巧易用的數位式上臂、腕式和穿戴式血壓監測儀的強勁需求。 Withings 的 BPM Vision 就是一個典型的例子。這款旅行裝大小、支援 Wi-Fi 的家用血壓監測儀配備大尺寸彩色顯示螢幕，於 2025 年 4 月獲得美國 FDA 批准，並於 2025 年 10 月在歐盟上市，新增了房顫檢測和內置心電圖 (ECG) 功能。隨著居家醫療基礎設施的日趨成熟以及消費者對互聯監測的理解不斷加深，預計這一趨勢將在整個預測期內持續推動居家照護行業的發展。

市場限制因素

儘管血壓監測設備市場發展勢頭強勁，但仍面臨許多限制因素。眾多製造商之間激烈的價格競爭，從跨國醫療技術公司到區域性專業廠商，持續對利潤率構成下行壓力，尤其是在手動血壓計和入門級數位血壓計領域。測量準確性問題依然令人擔憂，因為袖帶尺寸不一致、測量方法不當以及儀器校準偏差都可能影響讀數的可靠性。對於未經嚴格臨床檢驗的低成本消費級設備而言，這一問題尤其突出。受「水俁汞公約」等環境和安全法規的推動，水銀血壓計正逐步被淘汰，這顛覆了傳統上可靠且經濟高效的產品類型，迫使製造商和醫療保健系統轉向表式血壓計和數位血壓計。家用血壓監測儀和連網連網型設備的保險報銷政策在不同地區仍有差異，限制了其在價格敏感型和低收入市場的普及。此外，與雲端同步連網監測設備相關的資料隱私和網路安全問題也增加了製造商在合規方面的難度。另一方面，新興市場數位素養和通訊基礎設施的匱乏限制了智慧血壓計和可連接應用程式的血壓計的普及。價格、準確性、監管、保險報銷和基礎設施等方面的障礙，儘管高血壓患病率上升、居家醫療普及以及數位醫療的融合等潛在促進因素依然強勁，但這些因素綜合起來，正在減緩市場成長速度。

區域說明

北美洲

到2025年，北美將佔全球血壓監測設備市場收入的39%。美國憑藉其完善的醫療保健基礎設施、高血壓高發生率、優厚的保險報銷體係以及連網監測設備的快速普及，在該市場佔主導地位。領先製造商的持續產品創新以及與遠端醫療的不斷融合，進一步鞏固了該地區的主導地位。

歐洲

歐洲是一個規模龐大且技術先進的區域市場，擁有完善的法規結構，包括CE認證、歐洲高血壓學會（ESH）制定的嚴格臨床檢驗標準，以及包括皇家飛利浦、Withings和博朗醫療在內的成熟製造商群體。諸如Withings在歐洲推出具備心房顫動（AFib）檢測功能的「BPM Vision」等產品，進一步鞏固了歐洲在德國、法國、英國、義大利和西班牙等國推動智慧家庭監測發展的重要地位。

亞太地區

亞太地區是成長最快的地區，這主要得益於中國、日本、印度、韓國和澳洲高血壓和心血管疾病發病率的上升、醫療基礎設施的快速發展以及對醫療衛生領域投資的增加。政府篩檢計畫的擴展、保險覆蓋範圍的擴大以及消費者對家用健康監測設備的日益普及，都在加速該地區的市場成長。

世界其他地區

涵蓋拉丁美洲、中東和非洲的「偏遠地區」代表著一個新興的成長前沿。由於醫療基礎設施的不斷改進、高血壓意識的提高和篩檢計畫的推廣，以及擴大經濟實惠的手動和數位監測設備取得管道的努力，高血壓監測的普及正在逐步推進。國際夥伴關係和公共衛生宣傳活動也正在促進當地分銷網路和篩檢系統的發展。

血壓監測設備市場的最新趨勢

2025年12月，皇家飛利浦公司完成了對健康監測技術公司EarlySense的收購，從而擴展了產品系列，其中包括血壓監測。策略意義：增強了飛利浦的連網家用健康監測產品系列，並擴展了其生命徵象監測技術基礎。

2025年9月，皇家飛利浦公司與Masimo續簽了多年策略夥伴關係，旨在整合病患監測技術。其中包括加速開發人工智慧驅動的臨床演算法，並將合作期限延長至2026年後。策略意義：鞏固飛利浦在多參數病患監測領域的領先地位，並拓展臨床技術夥伴關係。

常問問題：

問題1：血壓監測設備市場的成長率是多少？

預計從 2026 年到 2034 年的預測期內，血壓監測設備市場將以 9.6% 的複合年成長率成長。

Q2. 血壓監測設備市場的市場規模有多大？

預計到 2025 年，血壓監測設備市場價值將達到 42 億美元，預計到 2034 年將達到 96 億美元。

Q3.哪些地區正在推動血壓監測設備市場的發展？

北美地區憑藉其完善的醫療保健基礎設施、高血壓患病率高、健全的保險報銷體係以及聯網監測設備的快速普及，預計將主導血壓監測設備市場，到2025年將佔全球銷售額的39%。亞太地區預計將成為預測期內成長最快的地區。

第四季：血壓監測設備市場的主要促進因素是什麼？

主要促進因素包括：全球高血壓負擔日益加重，全球超過 11.3 億成年人受其影響，每年造成超過 760 萬人死亡；消費者越來越偏好居家和自我監測；數位設備和連網型設備的快速技術進步；老年人口不斷成長和慢性病患病率上升；以及遠端醫療和遠端患者監護生態系統的擴展。

Q5. 血壓監測設備市場的主要參與者有哪些？

主要公司包括皇家飛利浦公司、通用電氣公司、A&D有限公司、Hill-Rom服務公司、美國診斷公司、Withings公司、Spacelabs Healthcare公司、博朗醫療公司、GF Health Products公司和Microlife公司。其他正在積極擴張的製造商，詳見競爭格局部分。

目錄

第1章：血壓監測設備市場報告簡介

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章：血壓監測設備市場摘要整理

  • 市場概覽

第3章：血壓監測設備市場關鍵因素分析

  • 血壓監測設備市場：市場促進因素
    • 全球高血壓與心血管疾病負擔日益加重
    • 人們越來越傾向於在家中進行自我測量。
    • 數位和互聯測量儀器的技術進步
    • 遠端醫療和遠端患者監護生態系統的擴展
  • 血壓監測設備市場的市場限制與挑戰
    • 價格壓力與市場碎片化
    • 由於汞的使用被淘汰，測量精度和局限性增加。
    • 保險報銷、資料隱私和基礎設施複雜性
  • 血壓監測設備市場：市場機遇
    • 無袖帶和人工智慧測量儀器的廣泛應用
    • 新興市場和居家醫療的擴張

第4章 影響分析：人工智慧、地緣政治、貿易和經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：血壓監測設備市場的波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的競爭

第7章：血壓監測設備市場評估

  • 依產品
    • 數位/自動血壓計
    • 手動血壓計
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 居家醫療
    • 其他
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章：血壓監測設備市場的競爭格局

  • 市場集中度與結構
  • 競爭定位與市場佔有率分析（加值服務）

第9章：血壓監測設備市場的新創企業資金籌措與投資趨勢

第10章 血壓監測設備市場：公司概況與產品概況

  • Koninklijke Philips NV
    • 公司簡介
    • 公司簡介
    • 財務概覽
    • 服務組合
    • 戰略方法/熵
  • General Electric Company
    • 產品系列
  • A&D Company, Limited
  • Hill-Rom Services, Inc.
  • American Diagnostic Corporation
  • Withings
  • Spacelabs Healthcare
  • Braun Healthcare
  • GF Health Products, Inc.
  • Microlife Corporation

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

目錄

第1章：血壓監測設備市場報告簡介

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章：血壓監測設備市場摘要整理

  • 市場概覽

第3章：血壓監測設備市場關鍵因素分析

  • 血壓監測設備市場：市場促進因素
    • 全球高血壓與心血管疾病負擔日益加重
    • 人們越來越傾向於在家中進行自我測量。
    • 數位和互聯測量儀器的技術進步
    • 遠端醫療和遠端患者監護生態系統的擴展
  • 血壓監測設備市場的市場限制與挑戰
    • 價格壓力與市場碎片化
    • 由於汞的使用被淘汰，測量精度和局限性增加。
    • 保險報銷、資料隱私和基礎設施複雜性
  • 血壓監測設備市場：市場機遇
    • 無袖帶和人工智慧測量儀器的廣泛應用
    • 新興市場和居家醫療的擴張

第4章 影響分析：人工智慧、地緣政治、貿易和經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：血壓監測設備市場的波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的競爭

第7章：血壓監測設備市場評估

  • 依產品
    • 數位/自動血壓計
    • 手動血壓計
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 居家醫療
    • 其他
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章：血壓監測設備市場的競爭格局

  • 市場集中度與結構
  • 競爭定位與市場佔有率分析（加值服務）

第9章：血壓監測設備市場的新創企業資金籌措與投資趨勢

第10章 血壓監測設備市場：公司概況與產品概況

  • Koninklijke Philips NV
    • 公司簡介
    • 公司簡介
    • 財務概覽
    • 服務組合
    • 策略舉措/熵
  • General Electric Company
    • 產品系列
  • A&D Company, Limited
  • Hill-Rom Services, Inc.
  • American Diagnostic Corporation
  • Withings
  • Spacelabs Healthcare
  • Braun Healthcare
  • GF Health Products, Inc.
  • Microlife Corporation

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0012

Blood Pressure Monitoring Devices Market Summary

Overview:

  • The Blood Pressure Monitoring Devices market is estimated at USD 4.20 billion in 2025 and is projected to reach USD 9.60 billion by 2034. Growth is anchored in the rising global burden of hypertension and cardiovascular disease, accelerating adoption of home-based and self-monitoring devices, and growing integration of digital, connected, and AI-enabled health technologies.
  • The global Blood Pressure Monitoring Devices market is growing at a CAGR of 9.6% during the forecast period from 2026 to 2034.
  • By product, the Digital/Automated Blood Pressure Monitors segment dominated the Blood Pressure Monitoring Devices market with a 64% share in 2025.
  • By end-user, the Home-Care Settings segment dominated the Blood Pressure Monitoring Devices market with a 58% share in 2025.
  • North America dominated the global Blood Pressure Monitoring Devices market revenue with a 39% share in 2025, representing the highest regional market share globally.

A blood pressure monitoring device is a diagnostic instrument used to measure systolic and diastolic arterial pressure in clinical, ambulatory, and home-care settings for the screening, diagnosis, and ongoing management of hypertension and cardiovascular disease. The market spans digital/automated blood pressure monitors, including wearable, upper arm-based, wrist-based, and finger-based devices that use oscillometric and increasingly cuffless sensing technologies, and manual blood pressure monitors, including mercury and aneroid sphygmomanometers that remain widely used for their low cost and auscultatory accuracy. Devices are deployed across hospitals, ambulatory surgical centers, home-care settings, and other care environments, with adoption accelerating as connected, Bluetooth- and Wi-Fi-enabled monitors integrate with mobile health applications, electronic health records, and remote patient monitoring platforms. Driven by the rising global prevalence of hypertension, an aging population, growing consumer health awareness, and continuous innovation in cuffless, AI-enabled, and atrial-fibrillation-detecting technologies, blood pressure monitoring devices have become essential tools underpinning both clinical cardiovascular care and the expanding home healthcare and digital health ecosystem.

Blood Pressure Monitoring Devices Market Key Growth Drivers

  • The rising global burden of hypertension is a foundational driver, with public health data indicating that more than 1.13 billion adults worldwide live with hypertension and that the condition contributes to over 7.6 million deaths annually, sustaining structural demand for screening and monitoring devices.
  • Growing consumer preference for home-based and self-monitoring is expanding demand for digital upper-arm, wrist, and wearable monitors, as patients seek to track hypertension conveniently outside clinical settings and share readings with physicians remotely.
  • Rapid technological advancement, including Bluetooth and Wi-Fi connectivity, cuffless and optical sensing, and AI-enabled atrial fibrillation detection, is broadening the functionality and clinical value of connected blood pressure monitors.
  • The rising geriatric population and increasing prevalence of obesity, diabetes, and sedentary lifestyles are elevating cardiovascular risk and expanding the patient pool requiring routine blood pressure monitoring.
  • Expansion of telehealth and remote patient monitoring ecosystems is increasing integration of connected blood pressure devices with mobile health apps, electronic health record systems, and virtual-care platforms.
  • Stringent accuracy and validation standards, including ISO 81060-2:2018+A1:2020 and protocols recognized by the European Society of Hypertension and the American Heart Association, are pushing manufacturers toward clinically validated, higher-accuracy devices.
  • Strategic investment, product launches, and M&A activity among leading manufacturers, including Philips' completed acquisition of EarlySense in December 2025 and its renewed multi-year patient-monitoring partnership with Masimo in September 2025, are strengthening connected monitoring portfolios.
  • The convergence of rising hypertension prevalence, home healthcare adoption, and digital health integration is expected to sustain steady double-digit-adjacent growth in the market through 2034.

Key Companies in Blood Pressure Monitoring Devices Market

The competitive landscape is led by the following active device manufacturers:

  • Koninklijke Philips N.V.
  • General Electric Company
  • A&D Company, Limited
  • Hill-Rom Services, Inc.
  • American Diagnostic Corporation
  • Withings
  • Spacelabs Healthcare
  • Braun Healthcare
  • GF Health Products, Inc.
  • Microlife Corporation

Factors Contributing to the Growth of the Blood Pressure Monitoring Devices Market

Market Drivers

Rising Global Burden of Hypertension and Cardiovascular Disease

The single most powerful driver of the Blood Pressure Monitoring Devices market is the sheer scale of the global hypertension burden. Public health surveillance indicates that more than 1.13 billion adults worldwide live with hypertension, and the condition is linked to over 7.6 million deaths annually, making it the leading modifiable risk factor for cardiovascular disease, stroke, and kidney failure. Despite this scale, awareness and treatment rates remain suboptimal in many regions, prompting public-health campaigns such as May Measurement Month to expand screening access. As cardiovascular disease incidence continues to rise alongside aging populations and lifestyle-related risk factors, demand for accurate, accessible blood pressure monitoring devices across hospitals, clinics, and homes continues to expand, anchoring market growth through 2034.

Growing Preference for Home-Based and Self-Monitoring

A structural shift toward home-based blood pressure management is a central growth engine for the market. Patients and physicians increasingly favor self-monitoring because it reduces healthcare costs, captures more representative readings than sporadic clinic visits, and helps identify white-coat and masked hypertension. This shift has driven strong demand for compact, easy-to-use digital upper-arm, wrist, and wearable monitors, exemplified by product launches such as Withings' BPM Vision, a travel-size, Wi-Fi-enabled home monitor with a large color display that received FDA clearance in the United States in April 2025 and launched in the European Union in October 2025 with added atrial fibrillation detection and on-device ECG. As home healthcare infrastructure matures and consumer familiarity with connected monitoring grows, this trend is expected to sustain the leadership of home-care settings across the forecast period.

Market Restraints

Despite strong momentum, the Blood Pressure Monitoring Devices market faces material constraints. Intense price competition among a large number of manufacturers, ranging from multinational medical technology companies to specialized regional producers, exerts continuous downward pressure on margins, particularly in the manual and entry-level digital device segments. Measurement accuracy concerns persist, as inconsistent cuff sizing, improper technique, and device calibration drift can compromise reading reliability, particularly for lower-cost consumer devices that lack rigorous clinical validation. The gradual phase-out of mercury-based sphygmomanometers, driven by environmental and safety regulations such as the Minamata Convention on Mercury, is disrupting a historically reliable and cost-effective product category and requiring manufacturers and healthcare systems to transition to aneroid and digital alternatives. Reimbursement for home blood pressure monitors and connected devices remains inconsistent across geographies, limiting adoption in price-sensitive and lower-income markets. Data privacy and cybersecurity concerns associated with connected, cloud-synced monitoring devices add compliance complexity for manufacturers, while limited digital literacy and connectivity infrastructure in emerging markets constrain adoption of smart and app-connected monitors. Together, these pricing, accuracy, regulatory, reimbursement, and infrastructure barriers temper the pace of growth, even as the underlying drivers of hypertension prevalence, home healthcare adoption, and digital health integration remain firmly intact.

Blood Pressure Monitoring Devices Market Segment Analysis

The Blood Pressure Monitoring Devices Market by Product (Digital/Automated Blood Pressure Monitors {Wearable Blood Pressure Monitors, Upper Arm-based Blood Pressure Monitors, Wrist-based Blood Pressure Monitors, and Finger-based Blood Pressure Monitors} and Manual Blood Pressure Monitors {Mercury Blood Pressure Monitors and Aneroid Blood Pressure Monitors}), End-User (Hospitals, Ambulatory Surgical Centers, Home-Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product

Dominant Subsegment: Digital/Automated Blood Pressure Monitors. The Digital/Automated Blood Pressure Monitors category is expected to dominate the market.

Dominant: Digital/Automated Blood Pressure Monitors ~ 64%

The Digital/Automated Blood Pressure Monitors segment accounted for 64% of the Blood Pressure Monitoring Devices market in 2025. Digital and automated monitors, spanning wearable, upper arm-based, wrist-based, and finger-based devices, are the leading product category because they offer user-friendly, one-button operation, automated oscillometric measurement, and increasing integration with mobile health applications, making them the preferred choice across both clinical and home-care environments. Upper arm-based digital monitors remain the clinical gold standard for accuracy and are widely recommended by cardiology societies, while wrist-based and finger-based devices are gaining traction for portability and convenience despite generally lower clinical accuracy. Wearable blood pressure monitors, including cuffless and continuous monitoring form factors, represent the fastest-growing product niche as manufacturers pursue optical and sensor-based technologies that reduce reliance on inflatable cuffs. Manual mercury and aneroid blood pressure monitors continue to hold a meaningful share in cost-sensitive and resource-limited settings, valued for their low cost, durability, and lack of dependence on batteries or connectivity, and aneroid devices in particular are gaining share as regulatory phase-outs of mercury-based devices continue. Nonetheless, the accuracy, convenience, and expanding connectivity features of digital and automated monitors secure the segment's clear leadership across the forecast period.

By End-User

Dominant Subsegment: Home-Care Settings. The home-care settings category is expected to dominate the market.

Dominant: Home-Care Settings ~ 58%

The Home-Care Settings segment accounted for 58% of the Blood Pressure Monitoring Devices market in 2025. Home-care settings lead the market because rising awareness of hypertension, growing preference for self-monitoring, and the increasing affordability and connectivity of digital blood pressure monitors have made at-home measurement the most common mode of routine blood pressure tracking. Patients managing chronic hypertension increasingly rely on validated home devices to track readings between clinical visits, share data with physicians, and detect conditions such as white-coat and masked hypertension that clinic-only measurement can miss. Hospitals remain a significant end-user, relying on both manual and automated devices for admission screening, continuous ward monitoring, and ambulatory blood pressure monitoring for diagnostic confirmation, and this segment continues to grow steadily as hospital infrastructure expands, particularly in emerging markets. Ambulatory surgical centers represent a smaller but growing end-user category, driven by the rising volume of outpatient procedures requiring perioperative blood pressure monitoring. While hospitals are expected to grow at a healthy pace given rising procedure volumes and continuous monitoring needs, the sheer scale and accelerating adoption of self-monitoring at home secure the home-care settings segment's clear leadership across the forecast period.

Blood Pressure Monitoring Devices Market Region Analysis

Dominant Region: North America

North America accounted for 39% of the global Blood Pressure Monitoring Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a well-established healthcare infrastructure, high prevalence of hypertension, strong reimbursement frameworks, and rapid adoption of connected and digital monitoring devices, particularly in the United States. North America hosts a dense concentration of leading manufacturers and a mature retail and clinical distribution network, and sponsors benefit from proximity to innovation hubs driving continuous product launches, such as Withings' BPM Vision and American Diagnostic Corporation's expanding Advantage monitor line. The region's aging population, high rates of obesity and cardiovascular disease, and strong consumer awareness of home health monitoring, combined with active regulatory clearance activity from the FDA, sustain substantial demand across hospital, ambulatory, and home-care channels. Continued investment in telehealth integration and connected health platforms anchors the region's continued leadership across the forecast period.

Dominant: North America ~ 39% (Largest)

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Blood Pressure Monitoring Devices market. The region's elevated CAGR is driven by rising hypertension and cardiovascular disease incidence, rapid expansion of healthcare infrastructure, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China is expanding hospital and primary-care screening infrastructure, Japan is advancing connected and wearable monitoring technologies, and India is emerging as both a large patient population and a growing manufacturing base offering cost-competitive digital devices. Government-led hypertension screening programs, expanding health insurance coverage, and rising consumer adoption of home health monitoring devices are accelerating uptake across the region, while local and multinational manufacturers scale distribution networks to reach underserved rural and semi-urban populations. The combination of high disease burden, expanding infrastructure, and rising consumer health awareness positions Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 39% of the global Blood Pressure Monitoring Devices market revenue in 2025. The United States dominates on the strength of its healthcare infrastructure, high hypertension prevalence, strong reimbursement environment, and rapid adoption of connected monitoring devices, while continued product innovation from leading manufacturers and expanding telehealth integration reinforce the region's leadership.

Europe

Europe is a large and advanced regional market, supported by established regulatory frameworks under CE marking, strong clinical validation standards set by the European Society of Hypertension, and a mature base of manufacturers including Koninklijke Philips N.V., Withings, and Braun Healthcare. Product launches such as Withings' European rollout of BPM Vision with AFib detection reinforce the region's role in advancing connected home monitoring across Germany, France, the United Kingdom, Italy, and Spain.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by rising hypertension and cardiovascular disease incidence, rapid healthcare infrastructure build-out, and growing healthcare investment across China, Japan, India, South Korea, and Australia. Expanding government screening initiatives, rising insurance coverage, and growing consumer adoption of home health monitoring devices are accelerating regional market growth.

Rest of World

The Rest of the World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding healthcare infrastructure, rising hypertension awareness and screening initiatives, and efforts to broaden access to affordable manual and digital monitoring devices are gradually increasing adoption, while international partnerships and public health campaigns support the build-out of regional distribution and screening capacity.

Blood Pressure Monitoring Devices Market Competitive Landscape

The Blood Pressure Monitoring Devices market is classified as Highly Competitive and Fragmented. A group of large, diversified medical technology players with global distribution and broad connected-health portfolios, including Koninklijke Philips N.V., General Electric Company, and Hill-Rom Services, Inc., anchor the upper tier of the market, while specialized and fast-scaling manufacturers such as A&D Company, American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF Health Products, Inc., and Microlife Corporation compete through product innovation, clinical validation, price competitiveness, and deep channel relationships across hospital, retail, and home-care distribution, sustaining intense competition across both digital and manual device categories.

The competitive landscape can be evaluated across the following dimensions:

  • Market concentration: Highly competitive and fragmented, with diversified global medtech players leading alongside a large field of specialized digital-health and traditional device manufacturers.
  • Leading players: Koninklijke Philips N.V., General Electric Company, and Hill-Rom Services, Inc. anchor the top tier through diversified patient-monitoring portfolios and global distribution networks.
  • Geographic reach: Leading manufacturers operate global distribution networks spanning hospital, retail, and e-commerce channels across developed and emerging markets.
  • Product portfolio strength: Top players offer end-to-end portfolios spanning manual sphygmomanometers, digital upper arm and wrist monitors, ambulatory blood pressure monitoring systems, and connected wearable devices.
  • Technology and connectivity: Bluetooth and Wi-Fi connectivity, mobile app integration, AI-enabled AFib detection, and cuffless sensing are increasingly decisive competitive differentiators.
  • Strategic partnerships: Tie-ups spanning digital health platforms, electronic health record systems, and remote patient monitoring providers, such as Philips' collaborations with Epic Systems and Masimo, extend reach and clinical integration.
  • M&A activity: Active consolidation, including Philips' completed acquisition of EarlySense in December 2025, is expanding connected home-monitoring portfolios among leading manufacturers.
  • Manufacturing and validation capabilities: Clinically validated accuracy, ISO 81060-2 compliance, and proprietary cuff and sensing technologies are key competitive moats.
  • Innovation focus: Cuffless and optical sensing, AI-enabled AFib detection, connected home monitoring ecosystems, and continued redesign of traditional manual devices for improved ergonomics and durability.

Blood Pressure Monitoring Devices Market Recent Developmental Activities

In December 2025, Koninklijke Philips N.V. completed its acquisition of EarlySense, a health-monitoring technology firm, expanding its home-based vital-sign monitoring portfolio, including blood pressure tracking capabilities. Strategic significance: Strengthens Philips' connected home health monitoring portfolio and broadens its vital-signs technology base.

In September 2025, Koninklijke Philips N.V. renewed a multi-year strategic collaboration with Masimo to integrate patient-monitoring technologies, including plans to accelerate development of AI-driven clinical algorithms through 2026 and beyond. Strategic significance: Reinforces Philips' multiparameter patient-monitoring leadership and extends its clinical technology partnerships.

Blood Pressure Monitoring Devices Market Segmentation

Blood Pressure Monitoring Devices Market by Product

  • Digital/Automated Blood Pressure Monitors
  • Wearable Blood Pressure Monitors
  • Upper Arm-based Blood Pressure Monitors
  • Wrist-based Blood Pressure Monitors
  • Finger-based Blood Pressure Monitors
  • Manual Blood Pressure Monitors
  • Mercury Blood Pressure Monitors
  • Aneroid Blood Pressure Monitors

Blood Pressure Monitoring Devices Market by End-Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Home-Care Settings
  • Others

Blood Pressure Monitoring Devices Market by Geography

  • North America Blood Pressure Monitoring Devices Market
  • United States Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Canada Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Mexico Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Europe Blood Pressure Monitoring Devices Market
  • Germany Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • United Kingdom Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • France Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Italy Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Spain Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Rest of Europe Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Asia-Pacific Blood Pressure Monitoring Devices Market
  • China Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Japan Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • India Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Australia Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • South Korea Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Rest of the World (RoW) Blood Pressure Monitoring Devices Market
  • Middle East Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • Africa Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
  • South America Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)

Key Takeaways from the Blood Pressure Monitoring Devices Market Report Study

  • Market size analysis for the current blood pressure monitoring devices market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global blood pressure monitoring devices market.
  • Various opportunities available for competitors in the blood pressure monitoring devices market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current blood pressure monitoring devices market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for blood pressure monitoring devices market growth in the future?

Target audience who can benefit from this Blood Pressure Monitoring Devices market report study

  • Blood pressure monitoring devices product providers
  • Research organizations and consulting companies
  • Blood pressure monitoring devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in blood pressure monitoring devices
  • Various end-users who want to know more about the blood pressure monitoring devices market and the latest technological developments in the blood pressure monitoring devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the blood pressure monitoring devices market?

The blood pressure monitoring devices market is projected to expand at a CAGR of 9.6% during the forecast period from 2026-2034.

Q2. What is the market size of the blood pressure monitoring devices market?

The blood pressure monitoring devices market is estimated at USD 4.20 billion in 2025 and is projected to reach USD 9.60 billion by 2034.

Q3. Which region dominates the blood pressure monitoring devices market?

North America dominated the Blood Pressure Monitoring Devices market with a 39% share of global revenue in 2025, supported by well-established healthcare infrastructure, high hypertension prevalence, strong reimbursement frameworks, and rapid adoption of connected monitoring devices. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the blood pressure monitoring devices market?

The principal drivers are the rising global burden of hypertension, which affects more than 1.13 billion adults worldwide and contributes to over 7.6 million deaths annually; growing consumer preference for home-based and self-monitoring; rapid technological advancement in digital and connected devices; the rising geriatric population and chronic disease prevalence; and expanding telehealth and remote patient monitoring ecosystems.

Q5. Who are the major players in the blood pressure monitoring devices market?

The major players include Koninklijke Philips N.V., General Electric Company, A&D Company, Limited, Hill-Rom Services, Inc., American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF Health Products, Inc., and Microlife Corporation, among other active manufacturers profiled in the Competitive Landscape section.

Table of Contents

1. Blood Pressure Monitoring Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumptions

2. Blood Pressure Monitoring Devices Market Executive Summary

  • 2.1 Market at a Glance

3. Blood Pressure Monitoring Devices Market Key Factors Analysis

  • 3.1 Blood Pressure Monitoring Devices Market Drivers
    • 3.1.1 Rising Global Burden of Hypertension and Cardiovascular Disease
    • 3.1.2 Growing Preference for Home-Based and Self-Monitoring
    • 3.1.3 Technological Advancements in Digital and Connected Monitoring
    • 3.1.4 Expanding Telehealth and Remote Patient Monitoring Ecosystems
  • 3.2 Blood Pressure Monitoring Devices Market Restraints and Challenges
    • 3.2.1 Pricing Pressure and Market Fragmentation
    • 3.2.2 Measurement Accuracy and Mercury Phase-Out Constraints
    • 3.2.3 Reimbursement, Data Privacy, and Infrastructure Complexity
  • 3.3 Blood Pressure Monitoring Devices Market Opportunities
    • 3.3.1 Cuffless and AI-Enabled Monitoring Scale-Up
    • 3.3.2 Emerging-Market and Home Healthcare Expansion

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1 United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Blood Pressure Monitoring Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Buyers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Blood Pressure Monitoring Devices Market Assessment

  • 7.1 By Product
    • 7.1.1 Digital/Automated Blood Pressure Monitors
      • 7.1.1.1 Wearable Blood Pressure Monitors
      • 7.1.1.2 Upper Arm-based Blood Pressure Monitors
      • 7.1.1.3 Wrist-based Blood Pressure Monitors
      • 7.1.1.4 Finger-based Blood Pressure Monitors
    • 7.1.2 Manual Blood Pressure Monitors
      • 7.1.2.1 Mercury Blood Pressure Monitors
      • 7.1.2.2 Aneroid Blood Pressure Monitors
  • 7.2 By End-User
    • 7.2.1 Hospitals
    • 7.2.2 Ambulatory Surgical Centers
    • 7.2.3 Home-Care Settings
    • 7.2.4 Others
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 United States Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.1.2 Canada Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.1.3 Mexico Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
    • 7.3.2 Europe
      • 7.3.2.1 Germany Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.2.2 United Kingdom Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.2.3 France Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.2.4 Italy Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.2.5 Spain Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.2.6 Rest of Europe Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 China Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.3.2 Japan Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.3.3 India Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.3.4 Australia Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.3.5 South Korea Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.3.6 Rest of Asia-Pacific Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
    • 7.3.4 Rest of World
      • 7.3.4.1 Middle East Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.4.2 Africa Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
      • 7.3.4.3 South America Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)

8. Blood Pressure Monitoring Devices Market Competitive Landscape

  • 8.1 Market Concentration and Structure
  • 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Blood Pressure Monitoring Devices Market Startup Funding and Investment Trends

10. Blood Pressure Monitoring Devices Market Company and Product Profiles

  • 10.1 Koninklijke Philips N.V.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Service Portfolio
    • 10.1.5 Strategic Initiatives / Entropy
  • 10.2 General Electric Company
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Portfolio
    • 10.2.5 Strategic Initiatives / Entropy
  • 10.3 A&D Company, Limited
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 Strategic Initiatives / Entropy
  • 10.4 Hill-Rom Services, Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 Strategic Initiatives / Entropy
  • 10.5 American Diagnostic Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 Strategic Initiatives / Entropy
  • 10.6 Withings
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 Strategic Initiatives / Entropy
  • 10.7 Spacelabs Healthcare
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 Strategic Initiatives / Entropy
  • 10.8 Braun Healthcare
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 Strategic Initiatives / Entropy
  • 10.9 GF Health Products, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 Strategic Initiatives / Entropy
  • 10.10 Microlife Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Portfolio
    • 10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Blood Pressure Monitoring Devices Market in Global (2023-2034)
  • Table 2: Blood Pressure Monitoring Devices Market in Global by Product (2023-2034)
  • Table 3: Blood Pressure Monitoring Devices Market in Global by End-Users (2023-2034)
  • Table 4: Blood Pressure Monitoring Devices Market in Global by Geography (2023-2034)
  • Table 5: Blood Pressure Monitoring Devices Market in North America (2023-2034)
  • Table 6: Blood Pressure Monitoring Devices Market in the United States (2023-2034)
  • Table 7: Blood Pressure Monitoring Devices Market in Canada (2023-2034)
  • Table 8: Blood Pressure Monitoring Devices Market in Mexico (2023-2034)
  • Table 9: Blood Pressure Monitoring Devices Market in Europe (2023-2034)
  • Table 10: Blood Pressure Monitoring Devices Market in Germany (2023-2034)
  • Table 11: Blood Pressure Monitoring Devices Market in United Kingdom (2023-2034)
  • Table 12: Blood Pressure Monitoring Devices Market in France (2023-2034)
  • Table 13: Blood Pressure Monitoring Devices Market in Italy (2023-2034)
  • Table 14: Blood Pressure Monitoring Devices Market in Spain (2023-2034)
  • Table 15: Blood Pressure Monitoring Devices Market in the Rest of Europe (2023-2034)
  • Table 16: Blood Pressure Monitoring Devices Market in Asia-Pacific (2023-2034)
  • Table 17: Blood Pressure Monitoring Devices Market in China (2023-2034)
  • Table 18: Blood Pressure Monitoring Devices Market in Japan (2023-2034)
  • Table 19: Blood Pressure Monitoring Devices Market in India (2023-2034)
  • Table 20: Blood Pressure Monitoring Devices Market in Australia (2023-2034)
  • Table 21: Blood Pressure Monitoring Devices Market in South Korea (2023-2034)
  • Table 22: Blood Pressure Monitoring Devices Market in Rest of Asia-Pacific (2023-2034)
  • Table 23: Blood Pressure Monitoring Devices Market in the Rest of the World (2023-2034)
  • Table 24: Blood Pressure Monitoring Devices Market in the Middle East (2023-2034)
  • Table 25: Blood Pressure Monitoring Devices Market in Africa (2023-2034)
  • Table 26: Blood Pressure Monitoring Devices Market in South America (2023-2034)
  • Table 27: Competitive Landscape
  • Table 28: Startup Funding and Investment Trends

List of Figures

  • Figure 1: Blood Pressure Monitoring Devices Market Drivers
  • Figure 2: Blood Pressure Monitoring Devices Market Restraints
  • Figure 3: Blood Pressure Monitoring Devices Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis (US, EU, Japan, China)
  • Figure 6: Porter's Five Forces Analysis
  • Figure 7: Competitive Analysis
  • Figure 8: Blood Pressure Monitoring Devices Market in Global (2023-2034)
  • Figure 9: Blood Pressure Monitoring Devices Market in Global by Product (2023-2034)
  • Figure 10: Blood Pressure Monitoring Devices Market in Global by End-Users (2023-2034)
  • Figure 11: Blood Pressure Monitoring Devices Market in Global by Geography (2023-2034)
  • Figure 12: Blood Pressure Monitoring Devices Market in North America (2023-2034)
  • Figure 13: Blood Pressure Monitoring Devices Market in the United States (2023-2034)
  • Figure 14: Blood Pressure Monitoring Devices Market in Canada (2023-2034)
  • Figure 15: Blood Pressure Monitoring Devices Market in Mexico (2023-2034)
  • Figure 16: Blood Pressure Monitoring Devices Market in Europe (2023-2034)
  • Figure 17: Blood Pressure Monitoring Devices Market in Germany (2023-2034)
  • Figure 18: Blood Pressure Monitoring Devices Market in United Kingdom (2023-2034)
  • Figure 19: Blood Pressure Monitoring Devices Market in France (2023-2034)
  • Figure 20: Blood Pressure Monitoring Devices Market in Italy (2023-2034)
  • Figure 21: Blood Pressure Monitoring Devices Market in Spain (2023-2034)
  • Figure 22: Blood Pressure Monitoring Devices Market in the Rest of Europe (2023-2034)
  • Figure 23: Blood Pressure Monitoring Devices Market in Asia-Pacific (2023-2034)
  • Figure 24: Blood Pressure Monitoring Devices Market in China (2023-2034)
  • Figure 25: Blood Pressure Monitoring Devices Market in Japan (2023-2034)
  • Figure 26: Blood Pressure Monitoring Devices Market in India (2023-2034)
  • Figure 27: Blood Pressure Monitoring Devices Market in Australia (2023-2034)
  • Figure 28: Blood Pressure Monitoring Devices Market in South Korea (2023-2034)
  • Figure 29: Blood Pressure Monitoring Devices Market in Rest of Asia-Pacific (2023-2034)
  • Figure 30: Blood Pressure Monitoring Devices Market in the Rest of the World (2023-2034)
  • Figure 31: Blood Pressure Monitoring Devices Market in the Middle East (2023-2034)
  • Figure 32: Blood Pressure Monitoring Devices Market in Africa (2023-2034)
  • Figure 33: Blood Pressure Monitoring Devices Market in South America (2023-2034)
  • Figure 34: Competitive Landscape
  • Figure 35: Startup Funding and Investment Trends